![](/img/cover-not-exists.png)
Factors affecting the benefit of insulin dose intensification in people with Type 2 diabetes: an analysis from the OpT2mise randomized trial
Schütz-Fuhrmann, I., Castañeda, J., Reznik, Y., Aronson, R., Conget, I., Liabat, S., Runzis, S., de Portu, S., Cohen, O.Language:
english
Journal:
Diabetic Medicine
DOI:
10.1111/dme.13279
Date:
October, 2016
File:
PDF, 117 KB
english, 2016